Pharma giant Roche starts cost-cutting programme
Swiss pharmaceutical giant Roche said on Friday it was launching a cost-cutting programme which could lead to job cuts
By Agencies |
ZURICH: Swiss pharmaceutical giant Roche said on Friday it was launching a cost-cutting programme which could lead to job cuts.
The company said in a statement that "mounting pressures to curb healthcare costs" in the United States and Europe were among the reasons for the move.
It added that more details on the measures and their potential impact on jobs would be announced before the end of the year.
The pharmaceutical giant, which makes drugs such as flu medication Tamiflu, currently employs 80,000 people.
Swiss newspaper Sonntag had reported on Sunday that the group was looking at a "massive reduction of posts."
In July, the group posted a growth of 37 percent in first half net profit.
The company said in a statement that "mounting pressures to curb healthcare costs" in the United States and Europe were among the reasons for the move.
It added that more details on the measures and their potential impact on jobs would be announced before the end of the year.
The pharmaceutical giant, which makes drugs such as flu medication Tamiflu, currently employs 80,000 people.
Swiss newspaper Sonntag had reported on Sunday that the group was looking at a "massive reduction of posts."
In July, the group posted a growth of 37 percent in first half net profit.
Download
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
Related Articles
Any relief rally in markets likely limited and temporary: David RocheADVERTISEMENT
